Literature DB >> 23588523

Biosimilars require scientifically reliable comparative clinical data.

Valderílio Feijó Azevedo.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23588523     DOI： 10.1590/s0482-50042013000100013

Source DB:  PubMed          Journal:  Rev Bras Reumatol        ISSN： 0482-5004


× No keyword cloud information.
  3 in total

Review 1.  Etanercept biosimilars.

Authors:  Valderilio F Azevedo; Nathalia Galli; Alais Kleinfelder; Julia D'Ippolito; Paulo C M Urbano
Journal:  Rheumatol Int       Date:  2014-07-01       Impact factor: 2.631

Review 2.  Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology.

Authors:  Eduardo Mysler; Carlos Pineda; Takahiko Horiuchi; Ena Singh; Ehab Mahgoub; Javier Coindreau; Ira Jacobs
Journal:  Rheumatol Int       Date:  2016-02-27       Impact factor: 2.631

Review 3.  Partnership for productive development of biosimilar products: perspectives of access to biological products in the Brazilian market.

Authors:  Morton Aaron Scheinberg; Paulo Antonio Oldani Felix; Igor Age Kos; Maurício De Angelo Andrade; Valderilio Feijó Azevedo
Journal:  Einstein (Sao Paulo)       Date:  2018-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.